Thomas W. Griffin
Hoofd Techniek/Wetenschap/O&O bij Janssen Oncology, Inc.
Profiel
Thomas W.
Griffin is currently a Vice President-Clinical Research & Development at Janssen Oncology, Inc. He previously worked as an Executive Director-Oncology Therapeutics at Amgen, Inc., an Executive Director-Clinical Discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, a Vice President-Clinical Research & Development at Cougar Biotechnology, Inc., and a Principal at Hoffmann-La Roche, Inc. Griffin holds a doctorate degree from Cornell University.
Actieve functies van Thomas W. Griffin
| Bedrijven | Functie | Begin |
|---|---|---|
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Hoofd Techniek/Wetenschap/O&O | 29-07-2009 |
Eerdere bekende functies van Thomas W. Griffin
| Bedrijven | Functie | Einde |
|---|---|---|
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Hoofd Techniek/Wetenschap/O&O | 13-07-2009 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van Thomas W. Griffin
| Cornell University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
